Warning: Potential Pancreatic Risks Linked to GLP-1 Weight Loss Injections Monday, November 24, 2025 glp1 tirzepatide semaglutide pancreatitis sideeffects weightloss nhs mhra medicationsafety yellowcard GLP-1 receptor agonists, such as tirzepatide (Mounjaro) and semaglutide (Wegovy), are popular injectable medications prescribed to support weight loss by reducing appetite and increasing feelings of fullness. Typically … Read More
UK Medicine Regulator Issues Heatwave Alert: Important Guidance for Medication Users Tuesday, July 15, 2025 heatwave medicines dehydration photosensitivity mhra medication safety diuretics temperature methotrexate As the UK continues to experience intense heatwaves, the Medicines and Healthcare products Regulatory Agency (MHRA) has issued an urgent alert for individuals on certain medications or with specific health conditions. … Read More